Search company, investor...

Predict your next investment

Angel Investor (Individual)

Investments

28

Portfolio Exits

5

About Kevin Ryan

Headquarters Location

Want to inform investors similar to Kevin Ryan about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Kevin Ryan News

Heritage Group Expands Investment Team and Announces Vice President Promotion

Jan 24, 2023

January 24, 2023 11:00 AM Eastern Standard Time NASHVILLE, Tenn.--( BUSINESS WIRE )--Heritage Group, a healthcare-focused private equity firm, is pleased to announce the promotion of Matt Tome to Vice President, as well as the addition of two new members to the investment team, Kevin Ryan, Vice President and Franklin Garstin, Associate. Matt Tome joined Heritage in 2019 as an Associate. Prior to joining Heritage, Matt was an Associate in the Debt Capital Markets group at Stephens Inc., where he worked on a range of leveraged finance transactions. Prior to working in debt capital markets, Matt was an analyst at Stephens working on mergers and acquisitions and capital raising transactions across a broad range of industries. “We are incredibly excited to announce Matt’s well-deserved promotion to Vice President. Matt has made meaningful contributions to the firm and created value across all aspects of the investment process, from thematic investment work to post-closing portfolio company value creation,” said Lauren Brueggen, Partner at Heritage Group. “In addition to his acumen as an investor, Matt is a wonderful steward of the firm’s culture, and we are pleased to acknowledge these accomplishments through this promotion,” said Rock Morphis and David McClellan, Founders of Heritage Group. Heritage is also excited to announce the expansion of its investment team with two recent additions to the team, which include Kevin Ryan, who joined as a Vice President, and Franklin Garstin, who has joined as an Associate. Kevin was previously the Director of Business Development for Southern Orthodontic Partners, a Shore Capital portfolio company, where he played an active role in growing the company from two doctors in one state to over 50 doctors across eight states. Prior to this, Kevin was an Associate at Pharos Capital Group, a healthcare-focused private equity firm, and started his career as an investment banking analyst with Stephens Inc. Franklin joined Heritage from Alvarez & Marsal, where he was a Senior Associate in Healthcare Transaction Advisory, and previously worked as an associate at Deloitte, where he focused on healthcare audit work. “We look forward to building upon the success of our strategic healthcare investment model and are pleased to welcome Kevin and Franklin as members of our growing team,” said Graham Hunter, Partner at Heritage Group. About Heritage Group Heritage Group is a Nashville, Tennessee based, healthcare-focused private equity firm with more than 35 years of experience financing and operating healthcare companies. Heritage has over $700 million of assets under management and seeks to make majority and minority investments in high-growth healthcare services and healthcare technology businesses that address the challenges of the U.S. healthcare system. The firm's limited partners include some of the leading healthcare organizations in the nation, including large provider systems, payers, and healthcare service providers, which collectively operate over 600 hospitals and insure more than 45 million lives. For more information, visit www.heritagegroupusa.com . Contacts

Kevin Ryan Investments

28 Investments

Kevin Ryan has made 28 investments. Their latest investment was in Everphone as part of their Series C - II on September 9, 2022.

CBI Logo

Kevin Ryan Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/1/2022

Series C - II

Everphone

$32M

Yes

3

6/21/2022

Seed VC - II

Validio

$15M

Yes

2

9/22/2021

Series A

Pearl Health

$18M

Yes

4

8/24/2021

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

6/28/2021

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/1/2022

6/21/2022

9/22/2021

8/24/2021

6/28/2021

Round

Series C - II

Seed VC - II

Series A

Seed VC

Series B

Company

Everphone

Validio

Pearl Health

Subscribe to see more

Subscribe to see more

Amount

$32M

$15M

$18M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

3

2

4

10

10

Kevin Ryan Portfolio Exits

5 Portfolio Exits

Kevin Ryan has 5 portfolio exits. Their latest portfolio exit was Marti on August 01, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

8/1/2022

Acq - Pending

$99M

1

8/25/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

8/6/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

10/3/2019

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

6/25/2018

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/1/2022

8/25/2021

8/6/2021

10/3/2019

6/25/2018

Exit

Acq - Pending

Acquired

Acquired

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.